XML 52 R38.htm IDEA: XBRL DOCUMENT v3.19.1
Earnings Per Common Share and Share Awards (Tables)
12 Months Ended
Dec. 31, 2018
Earnings Per Share [Abstract]  
Computation Of Basic And Diluted Earnings Per Share
The following table sets forth the computation of basic and diluted earnings per share for the years ended December 31:
(in thousands, except per share amounts)
2018
 
2017
 
2016
Net income attributable to the Company
$
21,892

 
$
25,707

 
$
19,523

Weighted average common shares outstanding – Basic
1,887

 
1,886

 
1,908

Incremental shares outstanding assuming the exercise of dilutive stock options and SARs (share-settled)
10

 
10

 
7

Weighted average common shares outstanding – Diluted
1,897

 
1,896

 
1,915

Basic earnings per common share
$
11.60

 
$
13.63

 
$
10.23

Diluted earnings per common share
$
11.54

 
$
13.56

 
$
10.19

Summary Of Share-Based Award Transactions
A summary of share-based award transactions for all share-based award plans follows:
(in thousands, except weighted average exercise price and average remaining contractual term)
Number
Of Shares
 
Weighted
Average
Exercise
Price
 
Average
Remaining
Contractual
Term (Years)
 
Aggregate
Intrinsic
Value
Outstanding as of January 1, 2016
22

 
$
57.04

 
3.93
 
$
945

SARs granted
5

 
93.87

 
 
 
 

SARs exercised
(2
)
 
32.00

 
 
 
 

Outstanding as of December 31, 2016
25

 
$
65.85

 
3.85
 
$
837

SARs granted
4

 
192.71

 
 
 
 

SARs exercised
(4
)
 
36.38

 
 
 
 
Outstanding as of December 31, 2017
25

 
$
93.40

 
3.98
 
$
2,624

SARs granted
4

 
188.71

 
 
 
 

SARs exercised
(1
)
 
41.50

 
 
 
 

Outstanding as of December 31, 2018
28

 
$
110.27

 
3.64
 
$
2,019

 
 
 
 
 
 
 
 
Exercisable as of December 31, 2018
27

 
$
107.05

 
3.53
 
$
2,019

 
 
 
 
 
 
 
 
Unvested as of December 31, 2018
1

 
$
188.71

 
6.38
 
$

Summary of Information of Fixed Stock Options
The following table summarizes information about SARs outstanding at December 31, 2018:
(in thousands, except exercise prices and average remaining contractual term)
 
SARs Outstanding at Year-End
 
SARs Exercisable at Year-End
Range of Exercise Prices
 
Number
Outstanding
 
Weighted
Average
Remaining
Contractual Life
 
Weighted
Average
Exercise
Price
 
Number
Exercisable
 
Weighted
Average
Exercise
Price
$
50.00

 
 
$
59.99

 
3

 
0.37
 
$
50.50

 
3

 
$
50.50

60.00

 
 
69.99

 
4

 
2.39
 
68.70

 
4

 
68.70

70.00

 
 
79.99

 
8

 
2.58
 
72.44

 
8

 
72.44

90.00

 
 
99.99

 
4

 
4.38
 
93.87

 
4

 
93.87

150.00

 
 
199.99

 
9

 
5.88
 
190.71

 
8

 
191.00

$
50.00

 
 
$
199.99

 
28

 
3.64
 
$
110.27

 
27

 
$
107.05

Share-Based Valuation Assumptions
The weighted average fair values for the SARs issued during 2018, 2017 and 2016 were $78.61, $55.40 and $28.75, respectively, and were estimated using the weighted average assumptions shown in the table below.
 
2018
 
2017
 
2016
Expected life in years
7.0
 
7.0
 
7.0
Volatility
39.0%
 
26.2%
 
28.9%
Interest rate
3.1%
 
2.0%
 
1.7%
Yield rate
0.8%
 
0.8%
 
0.7%
Schedule of Weighted Average Grant Date Fair Value of Stock Awards Plans
The estimated weighted average grant-date fair value of SARs granted for the years ended December 31, was as follows:
 
2018
 
2017
 
2016
Exercise price equal to market price on date of grant:
 
 
 
 
 
Weighted average market price
$
188.71

 
$
192.71

 
$
93.87

Weighted average grant-date fair value
$
78.61

 
$
55.40

 
$
28.75